Gryphon Therapeutics
Latest round
- Series B
Last raised
- Jan 2002
Total raised
- $26M
Investors
- 4
About Gryphon Therapeutics
Gryphon Therapeutics, Inc. is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics.
Who invested in Gryphon Therapeutics
4 investors across 1 round
See all investors in Gryphon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 28, 2002
Amount
$26M
Investors
Questions about Gryphon Therapeutics
Who invested in Gryphon Therapeutics?
Gryphon Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gryphon Therapeutics raised?
Gryphon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gryphon Therapeutics last raise money?
Gryphon Therapeutics's most recent round on record is a Series B, in Jan 2002.
What does Gryphon Therapeutics do?
Gryphon Therapeutics is a pharmaceuticals company.
Where is Gryphon Therapeutics headquartered?
Gryphon Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Gryphon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Gryphon Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Gryphon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.